GeoVax Labs, Inc. Provides Clinical Studies Update
ATLANTA, Aug. 5 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based HIV/AIDS vaccine development company, today announced updates on its ongoing and planned human clinical
"We have two main areas of focus for our HIV/AIDS vaccine - ...
Omeros Appoints New Vice President of Clinical Development
SEATTLE, Aug. 5 /PRNewswire/ -- Omeros Corporation today announced the appointment of Stephen R. Murray, M.D., Ph.D. as Vice President of Clinical
Development. Dr. Murray will oversee clinical
trial strategies and protocols at Omeros, and currently is leading the ongoing clinical
Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
SEATTLE, WA, Aug. 4 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX:ONY) (the "Company") today announced the appointment of Diana Hausman, M.D., as Vice President, Clinical
Development at Oncothyreon. In this position, Dr. Hausman will be responsible for planning and implementing ...
OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.
FT. LAUDERDALE, Fla., Aug. 4 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical
trials announced today that the company has acquired the EDC assets of UK based, clinical
software provider, Lo...
Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
BEIJING, Aug. 4 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
(NYSE AMEX: SVA ), a leading provider of vaccines in China, announced today
that the clinical
trial of its A/H1N1 influenza vaccine is proceeding well.
All of the volunteers received their first shot of the vaccine and, during the
Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
BEIJING, Aug. 3 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX: SVA ),
a leading provider of vaccines in China, announced today that the clinical
trial of its A/H1N1 influenza vaccine is proceeding well. All of the
volunteers have received their first shot of the vaccine and, during th...
Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS/SaaS Clinical Trials Collaboration Software
Terrosa Technologies, a provider of Cloud and SaaS migration services and SaaS based applications, announces it has exclusive world wide sales, marketing and distribution responsibilities with Integrated Clinical
Solutions for its Inclinicalperform application. Inclinicalperform is software-as-a-...
Growing Midwestern Clinical Research Organization Selects OmniComm Systems to Provide eClinical Solutions for Phase IV Studies
FT. LAUDERDALE, Fla., July 30 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical
trials announced today that a growing US Clinical
Research Organization (CRO) has selected OmniComm to pr...
Seasoned Dermatologist Nissan Pilest of Irvine, CA, Joins SDS Clinical Trials as Clinical Investigator for Dermatology Division
A new dermatology division is being added to the slate of SDS Clinical
Trials. Nissan Pilest, Medical Director of Total Dermatology in Irvine, Ca, will be a primary investigative physician upon the division launch.
Orange County, CA (PRWEB) July 28, 2009 -- Well known ...
Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
SAN DIEGO, Calif., July 28 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) and its subsidiary Tissue Repair Company (TRC) today provided an update on the completion of their MATRIX Phase 2b clinical
study and announced plans to provide detailed safety and efficacy...
RadMD First to Offer CME-Certified Education and Training For Medical Imaging in Clinical Trials
DOYLESTOWN, Pa., July 28 /PRNewswire/ -- RadMD, Inc. ( www.rad-md.net ) has become the first company to offer a broad range of accredited CME courses in the area of medical imaging for pharmaceutical, medical device and biotech clinical
The comprehensive education a...
PacificGMP and USC to Collaborate on Recombinant Protein Development and Manufacturing for Phase 1 Clinical Trial
SAN DIEGO and LOS ANGELES, July 27 /PRNewswire/ -- PacificGMP, the leader in single-use bioprocessing for development and manufacturing for its client partners, and the University of Southern California (USC) announced today that they have signed an agreement whereby PacificGMP will prov...
PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2
SOUTH PLAINFIELD, N.J., July 27 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the initiation of a Phase 2 clinical
trial of PTC299 in adult patients with neurofibromatosis type 2 (NF2), a rare genetic disorder that causes the development of non-malignant brain tumors....
Histogen Hair Regrowth Clinical Trial Presented at ISHRS Annual Meeting
Data shows statistical significance at three key efficacy endpoints
San Diego, CA (PRWEB) July 27, 2009 -- Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts grown under embryonic conditions, shared the resu...
Free Webinar on Safer Clinical Hand-Offs Offered by Compirion Healthcare
ELM GROVE, Wis., July 23 /PRNewswire/ -- With the number of hand-offs involved in the day-to-day operations of patient care, the potential for error due to the communication process is considered a high risk. A webinar, titled Safer Clinical
Hand-Offs Now or Never: A Primary Strategy t...
Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)
BEIJING, July 22 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX:
SVA ), a leading provider of vaccines in China, today announced that it has
initiated dosing today in its clinical
trial of various Panflu vaccine
candidates for pandemic influenza A (H1N1). Results are expected in Septem...
Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
THE WOODLANDS, Texas, July 22 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ) will release its second quarter 2009 financial results on Tuesday, July 28, 2009 before the financial markets open. Lexicon management will hold a conference call to dis...
Magellan Diagnostic Businesses to Feature Automated Systems and Diagnostic Tests at Clinical Lab Expo
CHELMSFORD, Mass., July 16 /PRNewswire/ -- Magellan Biosciences, an emerging leader in clinical
diagnostics, will feature a variety of automated systems and diagnostic tests designed to help doctors make faster, more-informed treatment decisions in Booth 3244 at the 2009 AACC/ASCLS Cli...
Novel Product for the Prevention of Post-Surgical Adhesion Formation Completes Phase I Clinical Study
GOTHENBORG, Sweden, July 14 /PRNewswire/ -- PharmaSurgics AB.
successfully completes Phase I clinical
study showing their novel candidate
drug PXL01 is safe and well tolerated. Initially developed to prevent
post-surgical adhesion formation following hand surgery the product combines
Beta Release of v3.0 of OpenClinica Clinical Trials Software
A beta version of the widely anticipated OpenClinica version 3.0 is currently available, including numerous new features and performance enhancements.
Cambridge, MA (PRWEB) July 14, 2009 -- Akaza Research announces the beta release of OpenClinica 3.0. OpenClinica 3.0 br...
MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus
ROCKVILLE, Md. , July 13 /PRNewswire/ -- MacroGenics, Inc. today announced the initiation of the PARADIGM trial, a Phase 2 clinical
study evaluating MGAWN1, a humanized monoclonal antibody, for the treatment of individuals with suspected central nervous system infection due to West Nile Viru...
Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
PLYMOUTH, Mass., July 9 /PRNewswire/ -- Harvest Technologies Corp. ( www.harvesttech.com ) announced today that the company sponsored 60-patient clinical
trial conducted at Sri Ramachandra Medical Center in Chennai, India using the company's BMAC System to treat patients with non-reconstructable...
Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity
SAN DIEGO, July 9 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today announced positive results from a 28-week dose-ranging study of pramlintide/metreleptin, a combination treatment comprising pramlintide, an analog of the natural hormone amylin, and metreleptin, an ana...
Funxional Successfully Completes Initial Clinical Trial of FX125L, an Anti-Inflammatory Drug With a Novel Mechanism of Action
CAMBRIDGE, England, July 8 /PRNewswire/ -- Funxional Therapeutics Ltd
(Funxional) has announced today the successful completion of the first Phase
I study with FX125L, an orally available small molecule which belongs to a
new therapeutic class named Broad Spectrum Chemokine Inhibitors (BSCIs)....
2009: Immunotec announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process
Immunotec Receives NHPD/Health Canada Authorization to Begin a Study on
the Effect of the Cysteine-Rich Whey Protein Isolate (Immunocal(R)) in
Combination with Physical Exercise on Muscle Function, Body Composition
and Inflammatory Cytokine Levels in Elderly Persons: A Randomized,...
Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
THE WOODLANDS, Texas, July 7 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has initiated a Phase 2 clinical
trial of LX1032 , the...
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
PRINCETON, N.J., June 29 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biopharmaceutical company, announced today that investigators at the Fred Hutchinson Cancer Research Center, Seattle, Washington, published a paper this morning...
Cordex Completes Production of ATPace(TM) Clinical Trial Material
LA JOLLA, Calif., June 29 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced today that it has successfully completed the production of the ATPace(TM) clinical
trial material (CTM) in preparation for planned pivotal clinical
trials. The protocol of these clinical
Lytix Biopharma and KAEL-GemVax Announce Joint Clinical Trial to Combine LTX-315 and GV1001 Cancer Immunotherapy
TROMS0, Norway and SEOUL, Korea, June 19 /PRNewswire/ -- The Norwegian
biopharmaceutical company Lytix Biopharma and Korean company KAEL-GemVax
today announced the signing of a collaborative agreement to test lead
compounds LTX-315 and GV1001 as a combination therapy for the treatment of
Matthew Lehman of SPRI Clinical Trials Speaks On Designing Trials For Success At The Trout Group Investor Relations Seminar
NEW YORK, June 18 /PRNewswire/ -- In designing and conducting clinical
trials, it is critical to meet FDA objectives while preventing program "drift," according to Matthew Lehman, chief operating officer of SPRI Clinical
Trials-Global, LLC in his remarks at a recent seminar for biotechnology compa...
Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections
ASHBURN, Va., June 18 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced positive provisional findings from its three phase 2 clinical
trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the...
ERT to Showcase Its Clinical Trials Portfolio at DIA's 45th Annual Meeting at Booth #507
PHILADELPHIA, June 15 /PRNewswire/ -- ERT (Nasdaq: ERES ), a leading provider of centralized ECG and eClinical technology, ePRO, and other services to the biopharmaceutical, medical device, and related industries, announced today that it will be showcasing its portfolio of products an...
Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media Summit
Panel Addresses Barriers to Care and the Threatening Impact of Diabetes in America
WASHINGTON, June 12 /PRNewswire-FirstCall/ -- A distinguished panel of clinical
and policy experts gathered by Novo Nordisk recently convened in Washington, D.C. to explore solutions to address the exponential ...
ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
Panel of leading biopharma executives will discuss how Earned Value Management can improve control over clinical
development costs, payments, and accruals and facilitate compliance with Sarbanes-Oxley at the DIA 45th Annual Meeting in San Diego.
Chicago, IL (PRWEB) June...
PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
PRINCETON, N.J., June 10 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical
development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced its participation at several international professional meetings d...
Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association
SOUTH SAN FRANCISCO, Calif., June 8 /PRNewswire/ -- Proteolix, Inc. today announced data from ongoing Phase 2 and Phase 1b clinical
trials of carfilzomib for the treatment of multiple myeloma at the 14th Congress of the European Hematology Association (EHA) in Berlin, Germany. Carfilzomib is the ...
LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
COPENHAGEN, June 4 /PRNewswire/ -- Santaris Pharma today announced that
the cancer drug EZN-2968 - an inhibitor of HIF-1alpha, jointly developed by
Enzon Pharmaceuticals and Santaris Pharma A/S - was well tolerated and showed
early signs of clinical
benefit in previously treated cancer patient...
Document Management Inefficiencies Cost Clinical Study Sites Time, Money
NEW YORK, June 2 /PRNewswire/ -- Document sharing inefficiencies in clinical
trials cost investigative sites and study sponsors time and money, according to a recent online poll by IntraLinks(R), the leading provider of critical information exchange solutions.
The survey revealed heavy...
ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
ClearTrial will lead panel of adaptive trial experts offering practical guidelines for designing and implementing adaptive studies. As adaptive clinical
trials become more prevalent, their operational planning challenges often remain overlooked in the clinical
development process. Adaptive tria...
Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use
NIH funds human clinical
testing of the cell trafficking MRI reagent, Cell Sense.
Pittsburgh, PA (Vocus) June 2, 2009 -- Celsense, Inc. announced today that it is one of the recipients in a 4-year $1.95M grant from the National Institutes of Health. The funded studies ...